Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06456411 · ClinicalTrials.gov registry record · NA

Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer

A NA study of Breast Carcinoma and Carcinoma, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
410
Enrollment target
1
Study location

NCT06456411 is a NA study of Breast Carcinoma and Carcinoma that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 410 participants, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06456411, a NA study of Breast Carcinoma and Carcinoma, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
410 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop objective tools for assessing perceived pain severity in cancer patients and survivors, evaluate the sustained effectiveness of non-pharmacological interventions such as virtual reality in reducing pain and medication use, and create tools for the early detection of neuropathy. Wireless, non-invasive neuroimaging methods, including functional near-infrared spectroscopy (fNIRS), will be used to support these objectives

Interventions

  • OTHER Questionnaire Administration
  • PROCEDURE Functional Near-Infrared Spectroscopy
  • OTHER Virtual Technology Intervention
  • OTHER Cold Stimulation

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2022-07-12
Est. Completion 2030-07-12
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT06456411

The ClinicalTrials.gov registry entry for NCT06456411 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (47% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT06456411 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06456411 about?

NCT06456411 is a clinical study titled "Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer". This study aims to develop objective tools for assessing perceived pain severity in cancer patients and survivors, evaluate the sustained effectiveness of non-pharmacological interventions such as virtual reality in reducing pain and medication use, and create tools for the early detection of neurop...

What is the current status of trial NCT06456411?

This trial is currently recruiting. It is a NA study. The enrollment target is 410 participants. The study started on 2022-07-12. Estimated completion is 2030-07-12.

What conditions does trial NCT06456411 study?

This clinical trial studies the following conditions: Breast Carcinoma, Carcinoma, Kidney Carcinoma.

What interventions are being tested in trial NCT06456411?

The interventions under investigation include: Questionnaire Administration (OTHER), Functional Near-Infrared Spectroscopy (PROCEDURE), Virtual Technology Intervention (OTHER), Cold Stimulation (OTHER).

Who is sponsoring clinical trial NCT06456411?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06456411 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.